Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

BIMI International Medical Inc. BIMI OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • CN • USD

SharesGrow Score
21/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

BIMI International Medical Inc. (BIMI) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 20/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $12M, +2684.1%/yr average growth. Net income is $22M (loss), growing at -520.3%/yr. Net profit margin is -189.3% (negative). Gross margin is 16.5% (+108.9 pp trend).

Balance sheet: total debt is $5M against $4M equity (Debt-to-Equity (D/E) ratio 1.35, moderate). Current ratio is 0.92 (tight liquidity). Debt-to-assets is 15.3%. Total assets: $36M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 17/100 (Fail), Moat 22/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

BIMI SharesGrow Score Overview

27/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 22/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — BIMI

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
BIMI: +2684.1%/yr revenue is, -520.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
17/100
Balance sheet BIMI: Debt-to-Equity (D/E) ratio 1.35 (moderate), Current ratio is 0.92 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
22/100
BIMI: Gross margin is 16.5% (+108.9 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 22/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
BIMI: Net profit margin is -189.3%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.01
Volume26.25K
Avg Volume (30D)1.28K
Market Cap$1.16K
Beta (1Y)-0.65
Share Statistics
EPS (TTM)-8.40
Shares Outstanding$2.67M
IPO Date2006-10-18
Employees296
CEOTiewei Song
Financial Highlights & Ratios
Revenue (TTM)$11.83M
Gross Profit$1.95M
EBITDA$-17.97M
Net Income$-22.39M
Operating Income$-15.34M
Total Cash$2.34M
Total Debt$5.46M
Net Debt$3.12M
Total Assets$35.71M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Company Info
CountryCN
ExchangeOther OTC
CurrencyUSD
ISINUS05552Q3011

Price Chart

Track all markets on TradingView
BIMI
BIMI International Medical Inc. ↗  ·  Other OTC
Healthcare • Medical - Pharmaceuticals
0.00 52WK RANGE 0.01

People Also View

LFLY
LFLY
Leafly Holdings, Inc.
$37.00
+0.00%
 NVACF
NVACF
Nova Cannabis Inc.
$1.26
-2.77%
 PETS
PETS
PetMed Express, Inc.
$2.35
-0.64%
 RAD
RAD
Rite Aid Corporation
$0.65
-16.81%
 MEDS
MEDS
TRxADE HEALTH, Inc.
$7.59
+4.55%
 CJJD
CJJD
China Jo-Jo Drugstores, Inc.
$1.52
-5.59%
 SSY
SSY
SunLink Health Systems, Inc.
$1.12
+16.15%
 FFLWF
FFLWF
Fire & Flower Holdings Corp.
$0.12
-44.37%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message